NoticiasBenzingaNovo Nordisk Announces New Retrospective Real-world Evidence For Type 2 Diabetes Showing Semaglutide Injection 2 Mg Was Associated With A Statistically Significant 6% Lower Risk Of Major Adverse Cardiovascular Events, Than Those Who Switched To... Novo Nordisk Announces New Retrospective Real-world Evidence For Type 2 Diabetes Showing Semaglutide Injection 2 Mg Was Associated With A Statistically Significant 6% Lower Risk Of Major Adverse Cardiovascular Events, Than Those Who Switched To... Benzinga 2026.09.29 10:35 (GMT+0) Abrir en Benzinga Otras noticias Goldman Sachs prevé un crecimiento del tráfico aéreo del 1,6% en agosto Scholastic adquirirá Cottage Door Press por 71 millones de dólares 1-800-Flowers venderá PersonalizationMall por 45 millones de dólares NeurAxis nombra a Craig Blanchard como director comercial Filial de Southland gana contrato de tubería de agua por 71 millones de dólares JPMorgan rebaja PepsiCo a Neutral en la segunda bajada de la semana
